154 studies found for:    Open Studies | "Aggression"
Show Display Options
Rank Status Study
21 Recruiting Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Conditions: Adult Acute Lymphoblastic Leukemia;   Adult Acute Myeloid Leukemia;   Adult Diffuse Large B-Cell Lymphoma;   Aggressive Non-Hodgkin Lymphoma;   Childhood Acute Lymphoblastic Leukemia;   Childhood Acute Myeloid Leukemia;   Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Childhood Diffuse Large B -Cell Lymphoma;   DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma;   Myelodysplastic/Myeloproliferative Neoplasm;   Prolymphocytic Leukemia;   Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Stage I Adult Hodgkin Lymphoma;   Stage I Aggressive Adult Non-Hodgkin Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage I Chronic Lymphocytic Leukemia;   Stage I Diffuse Large B-Cell Lymphoma;   Stage I Mantle Cell Lymphoma;   Stage I Small Lymphocytic Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage II Chronic Lymphocytic Leukemia;   Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma;   Stage II Contiguous Mantle Cell Lymphoma;   Stage II Diffuse Large B-Cell Lymphoma;   Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma;   Stage II Non-Contiguous Mantle Cell Lymphoma;   Stage II Small Lymphocytic Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Aggressive Adult Non-Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Diffuse Large B-Cell Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage III Small Lymphocytic Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Aggressive Adult Non-Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Diffuse Large B-Cell Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Small Lymphocytic Lymphoma;   T-Cell Prolymphocytic Leukemia;   Waldenstrom Macroglobulinemia
Interventions: Drug: Atorvastatin Calcium;   Drug: Fludarabine Phosphate;   Radiation: Total-Body Irradiation;   Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclosporine;   Drug: Mycophenolate Mofetil;   Procedure: Peripheral Blood Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis
22 Unknown  Preventing Aggression In Veterans With Dementia (PAVED) - Telephone Sub-Study With Rural Veterans
Conditions: Dementia;   Pain
Intervention: Behavioral: Preventing Aggression in Veterans with Dementia (PAVeD)
23 Recruiting Antisocial Behavior on Healthcare Professionals in an Emergency Unit.
Condition: Rudeness/Incivility, Aggression or Violence Against Healthcare Workers in an Ophthalmic Emergencies Unit.
Intervention:
24 Recruiting Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression
Condition: Traumatic Brain Injury
Interventions: Drug: Buspirone;   Drug: Placebo
25 Unknown  Memantine on Aggression and Agitation of Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
26 Unknown  Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry
Conditions: Schizophrenia;   Psychosis
Intervention: Drug: Quetiapine XR
27 Recruiting The Effects of Midazolam on the Quality of Postoperative Recovery
Conditions: Postoperative Period;   Anxiety;   Fatigue;   Depression;   Aggression
Interventions: Drug: Midazolam;   Drug: NaCl (sodium chloride) 0,9%
28 Not yet recruiting Smoking Influence on Apoptosis in Periodontitis
Conditions: Chronic Periodontitis;   Aggressive Periodontitis
Intervention:
29 Unknown  Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Valproate;   Drug: Risperidone;   Drug: Placebo;   Drug: Stimulant medication;   Behavioral: Behavioral family counseling
30 Recruiting A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
Conditions: Advanced Solid Tumors;   Aggressive B-cell Lymphomas
Interventions: Biological: MEDI6469/tremelimumab;   Biological: MEDI6469/MEDI4736;   Biological: MEDI6469/rituximab;   Biological: MEDI6469
31 Recruiting OPTIMAL>60, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
Condition: CD20+ Aggressive B-Cell Lymphoma
Interventions: Drug: Conventional Vincristine;   Drug: Liposomal Vincristine;   Drug: Ricover-scheme rituximab;   Drug: optimised rituximab-schedule
32 Recruiting Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer
Conditions: Symptomatic, Aggressive, Sporadic, Unresectable, Locally;   Advanced/Metastatic Medullary Thyroid Cancer (MTC)
Intervention: Drug: Vandetanib 300 mg
33 Recruiting Adapting Dialectical Behavior Therapy for Children in Residential Care
Condition: Emotion Regulation, Verbal Aggression, Physical Aggression, Irritability, Anger
Interventions: Behavioral: DBT for children;   Behavioral: Supportive-Educational therapy
34 Recruiting Treatment of Children With Peer Related Aggressive Behavior (ScouT)
Condition: Oppositional Defiant Disorder
Interventions: Behavioral: Social Skills Training;   Behavioral: Treatment Program with techniques to activate resources
35 Recruiting Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Conditions: Rectal Diseases;   Rectal Neoplasms;   Gastrointestinal Diseases;   Gastrointestinal Neoplasms
Intervention: Procedure: new functional magnetic resonance imaging (MRI) protocols
36 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
37 Recruiting Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
Condition: Papillary Thyroid Cancer
Interventions: Procedure: diffusion weighted (DW) MRI;   Procedure: dynamic contrast agent (DCE) MRI
38 Recruiting Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)
Condition: Pituitary Tumors
Intervention:
39 Recruiting Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status
Condition: Prostatic Neoplasms
Interventions: Procedure: PET-MR 18f-FACBC;   Procedure: histology (gold standard)
40 Recruiting Nitro-oxidative Stress in Periodontitis
Conditions: Chronic Periodontitis;   Aggressive Periodontitis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years